Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bikov (Manchester, United Kingdom), M. Meszaros (Budapest, Hungary), P. Horvath (Budapest, Hungary), Z. Lazar (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), A. Kis (Budapest, Hungary), L. Kunos (Budapest, Hungary). The role of complement factor H and clusterin in obstructive sleep apnoea. 1333

Member's Comments

No comment yet.

Related content which might interest you: The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 The role of hyaluronan metabolism in obstructive sleep apnoea Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020 The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 The role of vitamin D in obstructive sleep apnoea syndrome Source: Breathe, 14 (3) 206; 10.1183/20734735.000618 Year: 2018 Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 The role of pro- and anti- inflammatory cytokines in the pathogenesis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Roles of periostin in patients with severe obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 The relationship between obstructive sleep apnea syndrome and apolipoprotein E allels Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009 Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006 The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005 5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Does obstructive sleep apnoea predispose to reduced renal function? Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009